Intrexon News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.08.19	Ausblick: Intrexon präsentiert Quartalsergebnisse (finanzen.net)
19.06.19	Surterra Wellness Enters Into $100 Mln Cannabinoid Licensing Deal With Intrexon (RTTNews)
07.05.19	Ausblick: Intrexon präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
06.03.19	6 Top Gainers In Healthcare Sector (XON, ACB, AVXL…) (RTTNews)
05.03.19	5 Top Losers In Healthcare Sector (EVOK, ENDP, XON...) (RTTNews)
26.02.19	Ausblick: Intrexon öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
20.12.18	Merck erweitert Vereinbarung mit US-Biotechunternehmen Intrexon (Dow Jones) Der Darmstädter Pharma- und Spezialchemiekonzern Merck hat eine Vereinbarung mit dem US-Biotechunternehmen Intrexon bei der Entwicklung von Krebstherapien erweitert.» mehr
20.12.18	Merck KGaA To Assign Chimeric Antigen Receptor T-cell Rights To Intrexon (RTTNews)
06.11.18	Ausblick: Intrexon stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net)
18.10.18	Oxitec to Develop 2nd Friendly™ Mosquito Strain Designed to Combat Malaria-Spreading Mosquitoes (PR Newswire)
18.10.18	Oxitec to Develop 2nd Friendly™ Mosquito Strain Designed to Combat Malaria-Spreading Mosquitoes (PR Newswire)
25.09.18	AMRN Heartens Investors, AKCA On Watch, ACRX Faces FDA Panel In Oct. (RTTNews)
18.06.18	FDA Places Clinical Hold On Ziopharm's Cancer Trial; Stock Down (RTTNews)
29.05.18	Isolation and Recombinant Expression of Key Enzyme for Opioid Production (PR Newswire)
21.05.18	Precigen Announces First Patient Dosed in Phase 1 Clinical Study of INXN-4001 (PR Newswire)
16.05.18	Photocure Announces Blue Light Cystoscopy with Cysview® Now Available for Surveillance of Bladder Cancer (PR Newswire)
14.05.18	Intrexon to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference (PR Newswire)
10.05.18	Intrexon Announces First Quarter 2018 Financial Results (PR Newswire)
03.05.18	Intrexon to Announce First Quarter 2018 Financial Results on May 10th (PR Newswire)
16.04.18	Exemplar Genetics Rare Neurological Disease Model Cleared by FDA for Commercial Research Use (PR Newswire)
29.03.18	ActoBio Therapeutics Greenlighted by FDA to Commence a Phase Ib/IIa Trial with AG019 for the Treatment of Early Onset Type 1 Diabetes (PR Newswire)
01.03.18	Intrexon Announces Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
28.02.18	Queens Sales Prices Hit All-Time High as Rents Fall to 2015 Levels (PR Newswire)
22.02.18	Intrexon to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1st (PR Newswire)
04.01.18	Intrexon's ActoBio Therapeutics to Present at Biotech Showcase 2018 on January 8 (PR Newswire)
02.01.18	Intrexon Corporation Annual CEO Letter (PR Newswire)
27.11.17	Intrexon Announces Key Management Appointments (PR Newswire)
10.11.17	Intrexon to Present at the Stifel 2017 Healthcare Conference (PR Newswire)
09.11.17	Intrexon Announces Third Quarter 2017 Financial Results (PR Newswire)
01.11.17	Intrexon to Announce Third Quarter 2017 Financial Results on November 9th (PR Newswire)
23.10.17	Intrexon and Arch Pharmalabs Collaborate on Fermentative Production of an API to Replace Existing Process Sourced from Animals (PR Newswire)
19.10.17	Intrexon CEO to Participate in World Food Prize Leadership Panel on Global Hunger (PR Newswire)
16.10.17	Intrexon Corporation Enters into $100 Million Preferred Stock Equity Facility (PR Newswire)
16.10.17	Intrexon Crop Protection Achieves Milestone in Development of Pioneering Self-Limiting Fall Armyworm Solution (PR Newswire)
16.10.17	Intrexon Crop Protection Achieves Milestone in Development of Pioneering Self-Limiting Fall Armyworm Solution (PR Newswire)
26.09.17	Kayne Anderson Rudnick Takes No. 1 Slot in Barron's "Top 100 Independent Financial Advisors" (PR Newswire)
19.09.17	Oxitec to Build State-of-the-Art Mosquito Egg Production Unit (PR Newswire)
19.09.17	Oxitec to Build State-of-the-Art Mosquito Egg Production Unit (PR Newswire)
19.09.17	Stock Performance Review on Biotech Industry -- Intrexon, Ampio Pharma, AmpliPhi Biosciences, and CorMedix (PR Newswire)
14.09.17	Biotech Sector Looking to Outperform in 2017 (PR Newswire)
11.09.17	Little-Known Biotech Breakthrough Could Save Millions Of Lives (PR Newswire)
05.09.17	Oxitec's Innovative Solution to Tackle Growing Diamondback Moth Pest Issue Begins Field Trials (PR Newswire)
05.09.17	Oxitec's Innovative Solution to Tackle Growing Diamondback Moth Pest Issue Begins Field Trials (PR Newswire)
31.08.17	Intrexon to Participate in Upcoming Investor Conferences (PR Newswire)
11.08.17	Covered Call reports for American Airlines, Hawaiian Holdings, Copa Holdings, Pan American Silver Corp and Intrexon include trade ideas that offer returns of 23% or more! (PR Newswire)
09.08.17	Intrexon Announces Second Quarter and First Half 2017 Financial Results (PR Newswire)
02.08.17	Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9th (PR Newswire)
26.07.17	How These Biotech Stocks are Performing? -- Intrexon, 22nd Century, Corcept Therapeutics, and Achaogen (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Part Grp Hldg	1’342.00	6.47 %	K V
Logitech Intl	80.28	3.21 %	K V
Lonza Grp	554.60	2.36 %	K V
Sonova Hldg	299.20	1.66 %	K V
CieFinRichemont	141.10	1.47 %	K V
Holcim	88.30	-0.20 %	K V
Givaudan	3’880.00	-0.21 %	K V
Zurich Insur Gr	546.20	-0.33 %	K V
Kuehne+Nagel Int	207.90	-0.72 %	K V
Sika	215.90	-0.83 %	K V

Nachrichten zu Intrexon Corp

Aktien Top/Flop

Meistgelesene Nachrichten